Insider at Audentes Therapeutics (BOLD) Makes Significant Sale of Stock

Tuesday, March 06, 2018 10:15 PM ET

Insider at Audentes Therapeutics (BOLD) Makes Significant Sale of Stock

An insider disposed of 866,420 shares of Audentes Therapeutics having a market value of approximately $30,421,232 today, as indicated in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 18,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 884,420 shares and have averaged 442,210 shares per transaction over this time period.

Insider buy/sell trading at Audentes Therapeutics is higher than the 285 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 319 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for Audentes Therapeutics insiders was also higher. Within the peer group there were 27,096,829 shares purchased and 13,769,904 shares sold with company insiders purchasing 66,303 shares on average.

For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to evaluate and write this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.